ANYO Labs- AI solutions in drug discovery
A research team at GU has for 2 years developed i-TripleD: a novel machine learning method that goes beyond state-of-the-art, using a totally unique approach to molecular screening, leading to new levels of sophistication, with unprecedented accuracy in screening power.
IVAs 100-lista 2023
Modern drug discovery (DD) suffers from major bottlenecks in speed, accuracy, and in finding new and unique drugs. To solve this, a research team at GU has for 2 years developed i-TripleD: a novel machine learning method that goes beyond state-of-the-art, using a totally unique approach to molecular screening, leading to new levels of sophistication, with unprecedented accuracy in screening power.
With our novel Ultra-Fast Screening approach, we can furthermore screen compounds several orders of magnitude faster than any current software found to date.
On a single computational node, almost 1 billion compounds can be screened for potency as well as pharmacodynamic and -kinetic properties in a single day.
This can lead to the democratisation of AI tools in DD, the possibility to explore the vast unknown chemical space for new and novel compounds never seen before, and save immeasurable resources and time downstream in DD.
Reach out to ANYO Labs for more information
